Related by context. All words. (Click for frequent words.) 52 Pantginis 50 Geoff Meacham 48 solanezumab 47 Dr. Pazdur 47 Amgen Prolia 46 motesanib 45 bifeprunox 45 ProSavin 45 iniparib 45 Xinlay 44 Pfizer inhaled insulin 44 lumiliximab 44 MyVax 44 iclaprim 44 ruxolitinib 44 gemifloxacin 44 fampridine SR 44 Vojo Vukovic MD Ph.D. 44 adjuvant colon cancer 44 vinflunine 43 Folotyn 43 pomalidomide 43 Serdolect 43 Asentar 43 Pagoclone 43 ponatinib 43 vosaroxin 43 LHRH analogues 43 NSABP C 43 Pirfenidone 43 tanespimycin 43 midstage studies 43 gepirone ER 43 Zybrestat 42 Oncogenex 42 bosutinib 42 axitinib 42 Zoraxel 42 riociguat 42 midstage clinical trial 42 Phenoptin 42 Fibrillex 42 SPARLON 42 TOLAMBA 42 parkinsonian symptoms 42 Benlysta belimumab 42 TroVax ® 42 TransVax 42 cetuximab Erbitux 42 dexanabinol 41 bapineuzumab 41 genotypic resistance 41 tecarfarin 41 apremilast 41 Merck KGaA Erbitux 41 KIACTA ™ 41 BNC# 41 canakinumab 41 hypersensitivity allergic reactions 41 rEV# 41 CDP# 41 Gaboxadol 41 PEG SN# 41 BEMA TM LA 41 KRAS status 41 PROSTVAC TM 40 methodological limitations 40 Synavive 40 Troxatyl TM 40 Vibativ 40 chemopreventive agent 40 urocortin 2 40 positive newsflow 40 SAR# [004] 40 ovarian suppression 40 Nicole Onetto MD 40 Fibrillex TM 40 Corlux 40 Rhucin R 40 methodological shortcomings 40 fidaxomicin Phase 3 40 TOCOSOL Camptothecin 40 midstage study 40 Orathecin 40 mGluR5 NAM 40 MAGE A3 ASCI 40 QT interval prolongation 40 ocrelizumab 40 ragweed allergic children 40 clinically meaningful differences 40 Aplidin 40 IMA# 40 Antioxidant supplements 40 amrubicin 39 elotuzumab 39 Vitaxin 39 Telintra 39 Lorianne Masuoka MD 39 Rezular 39 ticagrelor Brilinta 39 #D#C# 39 Gattex 39 COLAL PRED 39 MyVax personalized immunotherapy 39 neuropsychiatric adverse 39 Saphris 39 non selective NSAIDs 39 GVAX 39 locoregional recurrence 39 Aurexis 39 Oglemilast 39 Hedgehog antagonist 39 olaparib 39 ganetespib 39 vismodegib 39 Pimavanserin 39 PI3 kinase inhibitors 39 S/GSK# 39 Anidulafungin 39 tremelimumab 39 Satraplatin 39 samalizumab 39 Gleevec Glivec 39 acute HAE attacks 38 Lu AA# 38 Phase #/#a trial 38 budesonide foam 38 macitentan 38 Zolopa 38 K ras mutations 38 Phenserine 38 pancreatic acinar cell 38 adipiplon 38 ThGRF 38 lurasidone 38 Millennium Velcade 38 CA4P 38 Archexin 38 GALNS 38 indiplon capsules 38 candidates Dyloject TM 38 OvaRex ® MAb 38 ADAGIO study 38 Tasigna prolongs 38 oral prodrug 38 alvespimycin 38 maribavir 38 TELCYTA 38 Flutiform ™ 38 Darinaparsin 38 Alequel 38 ANCHOR trial 38 taxane refractory 38 huC# DM4 38 cediranib 38 Myriad Flurizan 38 TBC# 38 enzastaurin 38 lintuzumab SGN 38 Zemplar Capsules 37 TNF blocker therapy 37 Betaferon Betaseron 37 BLA filing 37 Desmoteplase 37 rindopepimut 37 briakinumab 37 Rezonic 37 HyQ 37 elacytarabine 37 LymphoStat B 37 PRT# 37 estramustine 37 uridine triacetate 37 Bapineuzumab 37 Tavocept 37 almorexant 37 tramiprosate Alzhemed TM 37 vidofludimus 37 paliperidone ER 37 fostamatinib disodium 37 MediGene focuses 37 NeoLipid drug 37 disinflationary trend 37 taxane resistant 37 oxypurinol 37 Apoptone 37 compound INCB# 37 bardoxolone methyl 37 falsehoods perpetuated 37 blood thinner apixaban 37 TNF alpha inhibitors 37 Mipomersen 37 cMET 37 overlapping toxicities 37 GRN# 37 inhaled iloprost 37 mg/m2 cohort 37 severe hypersensitivity reactions 37 MGN# 37 Tasimelteon 37 novel trazodone formulation 37 T DM1 37 Xcytrin R 37 VNP#M 37 HGS ETR2 37 anticancer activity 37 Triolex 37 nalbuphine ER 37 antiresorptive 37 Fusilev 37 Silenor NDA 37 Relovair 37 figitumumab 37 PRIMO CABG 37 Liposomal Grb 2 37 oncologic diseases 36 breast cancer pill Tykerb 36 valopicitabine 36 VELCADE novel 36 immune modulating 36 BRAF V# mutation 36 tonabersat 36 SNT MC# 36 approve Arcoxia 36 Cimzia TM 36 CONBRIZA 36 includes TOLAMBA TM 36 shuffled pedophile priest 36 LE DT 36 demonstrated antitumor activity 36 lenalidomide dexamethasone 36 cytotoxic therapies 36 olanzapine LAI 36 Lupuzor 36 intravenous bisphosphonates 36 Granisetron Hydrochloride Injection 36 AVERROES 36 mTOR inhibitors 36 oral anticoagulants 36 Subgroup analyzes 36 MetMAb 36 cannabinor 36 hematological toxicity 36 HuMax CD4 36 Memryte 36 adjuvanted flu 36 Pazopanib 36 Prodarsan 36 IIa trial 36 blood clot dissolving 36 Somatuline Autogel 36 Allovectin 7 ® 36 painkiller Prexige 36 ELND# 36 Virulizin ® 36 Neupro patch 36 AZILECT ® 36 lymphomas leukemias 36 cyclist Wouter Weylandt 36 lipid lowering therapies 36 phase Ib 36 Evoltra TM 36 galiximab 36 Tarceva TM 36 phase IIb study 36 metastatic sarcoma 36 heavily pretreated 36 6R BH4 36 REMUNE R 36 TheraCIM 36 evaluating Prochymal 36 Aclasta Reclast 36 Troxatyl 36 multitargeted 36 iii Cubist 36 BCR ABL mutation 36 efficacy endpoint 36 Selzentry Celsentri 36 ENTEREG ® 36 refractory acute myeloid 36 EGFR mutation positive 35 Fast Track designations 35 PROVIGIL 35 phase IIa 35 Onalta ™ 35 imatinib resistance 35 JAK#/JAK# inhibitor 35 uh ruh 35 Ceflatonin 35 OvaRex R 35 tolerability profiles 35 Removab 35 canagliflozin 35 fusion enhancers 35 SOM# 35 Phase IIb trials 35 Linjeta TM 35 oral anticancer 35 subgroup analyzes 35 Fanconi syndrome 35 anti angiogenic agents 35 anti HBc 35 randomized discontinuation trial 35 Azixa MPC 35 ARIKACE ™ 35 grim prognoses 35 Plenaxis R 35 EEG abnormalities 35 proteasome inhibitor 35 BioNumerik 35 talactoferrin 35 dimebon latrepirdine 35 triphendiol 35 randomized Phase 2b 35 oral picoplatin 35 follicular Non Hodgkin 35 TLR8 agonist 35 MS spasticity 35 Reversible Posterior Leukoencephalopathy Syndrome 35 Ms Buchtmann 35 tubulin inhibitor 35 endothelin antagonist 35 hematological indications 35 Rhucin ® 35 riluzole 35 Phase IIB clinical 35 placebo controlled clinical trials 35 Afatinib 35 anti EGFR antibody 35 taspoglutide 35 humanised monoclonal antibody 35 Budesonide foam crofelemer 35 PASI scores 35 Entereg R 35 POSIDUR TM 35 ularitide 35 triglyceride lowering 35 ozarelix 35 skeletal sarcomere activator 35 drug Amevive 35 PDE# inhibitors 35 iroxanadine 35 ostarine 35 hematologic cytogenetic 35 CA9 SCAN 35 newsflows 35 Zemiva TM 34 leading oral taxane 34 PROCHYMAL 34 induced tumor regression 34 BrachySil 34 Azixa 34 Avastin adjuvant 34 dirucotide 34 recessionary headwinds 34 pharmacodynamic markers 34 mTOR inhibition 34 DACH platinum 34 CR# vcMMAE 34 PNH patients 34 initiate Phase 2b 34 Downside risks 34 Phase IIIb clinical 34 velafermin 34 receptor tyrosine kinase inhibitor 34 efficacy endpoints 34 Prestara 34 recombinant interferon 34 discomfort Sicherer 34 ASA# 34 indolent NHL 34 vaginal lidocaine 34 RGB # 34 subclinical cardiovascular disease 34 EndoTAG TM 34 ASONEP 34 ICA # 34 PRECISE Trial 34 Reclast Aclasta 34 Prochymal 34 macroeconomic headwinds 34 ocular formulation 34 www.soliris.net 34 supratherapeutic doses 34 Phase IIa trial 34 Mevacor OTC 34 omega interferon 34 imexon 34 efficacy tolerability 34 ALK inhibitors 34 MEK inhibitors 34 R alvimopan 34 GLP toxicology studies 34 phase IIb trial 34 novel oral anticoagulant 34 JAK#/JAK# inhibitor CYT# 34 romidepsin 34 IMC #F# 34 skeletal metastases 34 Michael Kaplitt Parkinson 34 Firdapse 34 Tracleer r 34 CDK inhibitors 34 factor TNF 34 tezampanel 34 SURFAXIN r 34 Behcet uveitis 34 ASG 5ME 34 relapsers 34 Torsades de Pointes 33 hematologic tumors 33 isavuconazole 33 potent neuroprotective 33 BEMA Buprenorphine 33 YONDELIS R 33 OMAPRO 33 Mesafem 33 therapeutic regimens 33 rALLy trial 33 Optiquel ™ 33 antiangiogenic drugs 33 Prodarsan ® 33 steep selloffs 33 Carfilzomib 33 Zavesca r 33 lingering mistrust 33 incyclinide 33 grade serous ovarian 33 secondary efficacy endpoints 33 Evoltra ® 33 midstage clinical trials 33 CytoFabTM 33 arbaclofen 33 restriction Depressed 33 zileuton 33 RRMS patients 33 DAC HYP 33 neratinib 33 viral reactivation 33 phase 2a 33 pramipexole 33 OECD Cotis 33 injectable formulations 33 lorvotuzumab mertansine 33 neuropsychiatric events 33 Elevated PSA 33 KRAS mutated 33 economist Paul Samter 33 cMET inhibitor 33 rALLy 33 blockbuster antidepressant Zoloft 33 Serdaxin 33 progressive multifocal 33 ProLindac 33 eculizumab therapy 33 pulmonary toxicity 33 IGF IR 33 therapeutic armamentarium 33 tumor necrosis 33 ragweed allergy immunotherapeutic 33 AVI ESPRIT technology 33 RSD# oral 33 SMT C# 33 debilitating deflationary spiral 33 anti angiogenic drugs 33 circulating endothelial cells 33 neovascular diseases 33 Phase Ib study 33 AML acute myeloid 32 Orazol 32 relapses 32 FACTIVE tablets 32 Tyzeka Sebivo 32 MMP inhibitors 32 leukaemias 32 darinaparsin Zinapar TM 32 CINOD 32 Restanza demonstrated 32 Premarket futures 32 Soliris TM eculizumab 32 registrational 32 omeprazole sodium bicarbonate 32 antineoplastic 32 pazopanib 32 danoprevir 32 molecular imaging radiopharmaceuticals 32 HQK 32 induced suicidality 32 PI3K inhibitors 32 antiangiogenic agents 32 asthma immunotherapeutic 32 p# inhibitor 32 serologic tests 32 preclinically 32 investigating Serdaxin 32 Soliris therapy 32 darbepoetin alpha 32 RoACTEMRA 32 biochemical abnormalities 32 brostallicin 32 European Medicines Evaluation 32 AQ4N 32 Urocidin 32 volociximab 32 antidiabetic medications 32 banned Darvon Darvocet 32 Syndrome RLS 32 DGAT1 inhibitors 32 PulmoBind ™ 32 Resolute DES 32 generation URAT1 inhibitor 32 vaccination Schuchat 32 setbacks 32 PulmoScience believes 32 bioabsorbable stent 32 ALB # 32 indications 32 AMPK activators 32 Orphan Drug designations 32 telomerase inhibition 32 clinical trials dacetuzumab SGN 32 PXD# 32 rBChE 32 prognostic biomarkers 32 inconvenience Southerners 32 OMP designation 32 IIa trials 32 gastrointestinal mucositis 32 hypoxia activated prodrug 32 GSK3B 32 gloomy predictions 32 PresbyLens ® 32 ritonavir boosted danoprevir 32 NP2 Enkephalin 32 Apo2L 32 XL# XL# XL# XL# 32 Akt inhibitor 32 nucleoside analogs 32 MAXY alpha 32 transgenically produced product 32 thetreatment 32 PulmoBind TM 32 Exelixis compounds 32 ELIQUIS 31 looming patent expirations 31 TransVax ™ 31 Vicinium TM 31 refractory Hodgkin 31 Bioenvision compounds under 31 Campath ® 31 statistically significant superiority 31 commercially exploitable mineralization 31 hematological tumors 31 non squamous histology 31 Phase IIb III 31 daily bactericidal antibiotic 31 VEGF inhibitors 31 anger Adlerstein 31 Alzheimer disease psychosis 31 JP-#/fipamezole 31 calcineurin inhibitors 31 class mGluR5 inhibitor 31 Phase #/#a clinical 31 ZACTIMA 31 Phase 2a trial 31 irritative 31 AQUAVAN R 31 MCSP respectively 31 adjuvant therapies 31 subclinical disease 31 patriotism Gration 31 MKC# PP 31 anti leukemic 31 targets VEGFR EGFR 31 perampanel 31 pills Xenadrine EFX 31 squalamine 31 rheumatoid arthritis psoriatic arthritis 31 counterfeit Alli 31 VDAs 31 dire prognoses 31 vascular disrupting agent 31 sirtuin activators 31 IND submission 31 Inovio pipeline 31 Valdoxan 31 severely bruised shin 31 PS# DARA 31 Coronel downfall came 31 condition Bazso 31 omeprazole widely 31 neuropsychiatric symptoms 31 AVI antisense 31 rufinamide 31 heavily pretreated patients 31 inhibit angiogenesis 30 SYN# 30 dose limiting toxicities 30 PROSTVAC ® 30 Q#IR 30 Conflicting signals 30 forodesine HCl 30 Alzhemed TM 30 nabilone 30 preexisting immunity 30 Pseudomonas aeruginosa infections 30 CYT# 30 adverse effects 30 Rifamycin SV MMX 30 SIRT1 activators 30 CELVAPAN H#N# 30 aberration Wexler 30 glioblastoma tumors 30 Phase 2b trial 30 Astana Vinokourov 30 haematological malignancies 30 myeloproliferative neoplasms MPNs 30 lung cancer NSCLC 30 iron fisted junta 30 Mechanistic studies 30 MGCD# clinical trials 30 severe hypomagnesemia 30 Phase Ib 30 bardoxolone 30 oral antiviral 30 mom anymore Veraflor 30 PLX cells 30 H#N# adjuvanted vaccine 30 neurocognitive deficits 30 treatmentof 30 labels Vivendi SA 30 multicenter clinical trials 30 KNS # 30 vivo coagulation 30 urate lowering 30 nonclinical studies 30 pharmacological interventions 30 Plavix cautioning 30 shigella diarrhea 30 stent thromboses 30 complement Coblation within 30 CML CP 30 Phase III 30 hoax Alderden 30 Currently Nymox 30 Buglova 30 connective tissue diseases 30 refractory CTCL 30 sideway trading 30 nasal formulation 30 multiple concomitant medications 30 Endeavor stent 30 clinical trials SGN 30 cardiovascular ischemic 30 cefixime 30 immunological disorders 30 Simdax 29 Orphan Drug status 29 TNF blocking 29 nonprescription NSAIDs 29 pharmacological therapies 29 Colacurcio Sr. s 29 misused Teuber added 29 NEUMUNE 29 molecular biomarkers 29 Visian Toric ICL 29 Trofex TM 29 dang motors 29 haematologic 29 farletuzumab 29 told BioWorld Today 29 dysfunction Zada 29 initiate Phase IIb 29 PFO closure 29 Hourly indicators 29 adjuvanted vaccines 29 spinal manipulative 29 Solasia 29 philosophic differences 29 Phase IIa clinical trials 29 hereditary deficiency 29 Oncophage vitespen 29 COMFORT II 29 Neupro ® 29 logistical hitches 29 astute prognosticators 29 intravenous bisphosphonate therapy 29 Van Esveld 29 GLPG# 29 blood thinner Exanta 29 pimavanserin 29 pediatric malignancies 29 Bracketed figures 29 rheumatoid arthritis juvenile idiopathic 29 oral PTH 29 neurological sequelae 29 Preclinical studies suggest 29 catheter occlusion 29 Cotara 29 MOZOBIL 29 thrombolytic agents 29 al Libi adamantly 29 Provecta 29 #/#/#-a negative sign [002] 29 phase IIa clinical 29 HIV associated lipodystrophy 29 right triceps irritation 29 CytoFab ™ 29 CYT# vascular disrupting 29 reversing heparin 29 include GALNS N 29 Leg cramps 29 toremifene citrate 29 Slightly Oversold 29 EMPOWER Study 29 Thrombotic events 29 CRu 29 myeloproliferative diseases 29 severe dermatologic toxicities 28 epidural steroids 28 armyworm outbreaks 28 forodesine hydrochloride BCX 28 Ganetespib 28 Cephalon Oncology 28 #.#-#.#/oz 28 GED aPC 28 oral hyoscyamine spray 28 Futures augured 28 Hwang fabrications 28 pain palliation 28 #.#-#.# oz 28 repeated rejections 28 Setbacks 28 causalties 28 surrogate markers 28 ZYBRESTAT fosbretabulin 28 Phase III trials 28 investigational therapies 28 bone sarcomas 28 Techs EUR USD 28 Phase 2a 28 Andrew Gledhill 28 ie antibody mediated 28 Arsenic trioxide 28 Impoverished Tajikistan 28 immunotherapeutic approaches 28 dose cohorts 28 Severe hypersensitivity reactions 28 secondary endpoints 28 options.Past performance 28 AGGRASTAT ® tirofiban hydrochloride 28 Achilles tendon rupture 28 Andrin Oswald CEO 28 TRAIL receptor antibodies 28 painful muscle spasms 28 actinic keratoses AKs 28 AZX# 27 multikinase inhibitors 27 #/#/#-a negative sign [001] 27 Frequent aftershocks 27 Shigamabs ® 27 Xerese 27 antiangiogenic activity 27 CSL Behring therapies 27 Sigma Tau SpA 27 Musical GLEE 27 rhC1INH 27 Mr Koukoulas 27 tamibarotene 27 #.#-#.#/tonne CFR 27 statistically significant correlations 27 disappointments 27 Xience V stent 27 uncertainities 27 Evenly Balanced 27 Empirical studies 27 virus HBV infection 27 Alvise Marino 27 OXi# 27 prodrome 27 Precautionary X rays 27 vigorous denials 27 Colon polyps 27 bavituximab monotherapy trial 27 mutated EGFR 27 debilitating affliction 27 RH1 27 #.#-#.#/tonne CFR cost 27 Astmax Emori 27 nitric oxide depletion 27 pharmacokinetic studies 27 Abgenix TopoTarget 27 multibillion dollar write downs 27 COMT inhibitors 27 deterioriation 27 Funtledeyer 27 scintigraphic 27 histologies 27 cognitive impairment associated 26 arsenic trioxide ATO 26 elevated creatine phosphokinase 26 countervailing pressures 26 AVN# [001] 26 inhalation anthrax infection 26 Epidemiologic studies 26 Christoph Weil 26 shin bruise 26 diarrheal disease malaria 26 lung pancreatic 26 ZADAXIN 26 refractory indolent NHL 26 heart valve stenosis 26 INDICATIONS 26 repeated stalemates 26 struggles Bahamonde 26 calf cramps 26 generation proteasome inhibitor 26 reinjury 26 influenza subtype 26 headwinds 26 pandemic influenza strains 26 Fresher barometers however 26 stiff headwinds 26 NB S# strontium malonate 26 categorical denials 26 Protamine 26 confirmatory 26 better childproof containers 26 targeting refractory relapsing 26 indomitable grace 26 GEM OS2 26 regenerating bone 26 ACL ruptures 26 limitations 26 cardioprotection 26 painful bunions 26 Starter Bartolo Colon 26 fuel Sajjil 26 airspeed readings 26 coagulation disorders 26 IIa clinical trial 25 metabolic readjustment 25 tuberculosis TB sepsis 25 danger Rundell 25 Nanocort 25 adulterated peanuts 25 uncapped seafloor gusher 25 leveraging AutEx 25 considerable dismay Salord 25 buoying sentiment 25 injectable depot 25 assurances 25 acute diffuse infiltrative 25 broker downgrades 25 steep selloff 25 Nimotuzumab 25 hematological cancers 25 remitting Multiple Sclerosis 25 pressures 25 fragilities 25 tumor malignancies 25 reassurances 25 Dr. Silvia Priori 25 plantar faciitis 25 recent closings Spillett 25 AMID Stapler TM 25 downward revisions 25 Recoverable PGM ounces 25 neurodegenerative diseases autoimmune diseases 25 messages SFist 25 Knee tendinitis 25 convalescing Fidel Castro 25 morale sapping defeats 25 strained triceps muscle 25 Enam Securities economist Sachchidanand 25 Lisfranc foot 25 warnings 25 stinging setbacks 25 multiple sclerosis rheumatoid arthritis 25 embed Lapan 25 disavowals 25 preclinical studies 25 disease modifying 24 negative publicity 24 Phase 2b clinical trials 24 pullbacks 24 extenuating factors 24 Moats blindsided 24 registrational trials 24 rating downgrades 24 Yusuf Heusen senior 24 etiological factors 24 inconclusive offensives 24 fibrotic diseases 24 topical anti infectives 24 causal relation 24 Applied Therapeutics ENT 24 Churchill Downs sandy loam 24 jitteriness 24 deceased Wolfinger 24 Bone metastases represent 24 circulatory dysfunction 24 insuperable obstacles 24 standoff Stacho 24 Significant Spacecraft Anomalies 24 generic pantoprazole 24 Now Sanyutei Kyoraku 24 pharmacodynamic 24 Khushigian hunches took 24 inflammation thrombosis oncology 24 setpoints programmable zone 24 prognosis 24 CFNAI MA3 suggests 24 Indication 24 Ducrozet 24 detached latissimus dorsi muscle 24 attempted self immolations 24 Lynnette Brammer 24 false dawns 24 therapies 24 Zarar Ahmad Muqbal 24 Yasi fury 24 laminitis painful often 24 symptoms Reisacher 24 sundowner prediction 24 Unconfirmed dispatch 24 procedural flaws 24 reoccurence 23 aerosol metered dose 23 seemingly unending rash 23 Pharmos pipeline 23 slipups 23 rheumatoid disease 23 Additionally Nexavar 23 forearm soreness 23 Opposes scheduling 23 cardiac tamponade cerebral edema 23 inflexibility Rimmer 23 Racial inequality 23 corneal wound 23 constraints 23 upheavel 23 anecdotal evidence 23 oncology indications 23 antidiabetic therapy 23 flare ups 23 misteps 23 Glassing causes horrific 23 dreaded laminitis 23 hiccups 23 bacterial contamination outbreaks 23 psychotherapeutic interventions 23 episodic reruns 23 downswings 23 biceps tendonitis 23 fumble itis 23 flareups 23 hefty writedowns 23 nagging Achilles 23 astonishing Siemionow 23 niggling knocks 23 severe anoxic brain 23 REVIS CB Pitt 23 unconfirmed rumors 23 periodic bouts 23 niggling hamstring strain 23 powerful RocketStream Protocols 23 self calibration BACnet 23 wobbles 23 strained adductor muscle 23 etiologic factors 23 TAXUS Liberte stent 23 developments 23 controversies dogging 23 ENSO neutral 23 myoglobinuria rhabdomyolysis 23 sexual harassment cronyism nepotism 22 Setback 22 coincident anomalies 22 jitters 22 spokesman Fred Opolot 22 deficiences 22 rejection 22 internal dissension 22 conflicting casualty tolls 22 Dahle Flesjaa 22 fruit flavored meads 22 Ed Chervenak political 22 unavailabilities 22 quicksand pits 22 inventory buildups 22 lingering aftereffects 22 strained elbow ligament 22 Seyfert galaxies 22 setback 22 Augment Injectable 22 cortical stimulation therapy 22 CTLA4 Ig product 22 Ligament damage